Overview

Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema

Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, placebo-controlled trial to evaluate the safety and efficacy of levosulpiride to improve retinal alterations due to diabetic macular edema and diabetic retinopathy
Phase:
Phase 2
Details
Lead Sponsor:
Carmen Clapp
Collaborators:
General Hospital Nuremberg & Paracelsus Medical University Nuremberg
Instituto de la Retina del Bajio SC (INDEREB)
Instituto de Neurobiología, Universidad Nacional Autonoma de Mexico (UNAM)
Instituto Mexicano de Oftalmologia
Instituto Mexicano de Oftalmologia (IMO)
Universidad Autónoma de Querétaro
Treatments:
Angiogenesis Inhibitors
Dopamine
Dopamine Agents
Ranibizumab
Sulpiride